Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Synchronous mucosal Schwann-cell hamartomas in a young adult suggestive of mucosal Schwann-cell harmatomatosis: a case report

  • Jeong Mo Bae1, 3,
  • Joon Young Lee2, 5,
  • Junhun Cho1,
  • Sang Ah Lim4, 5 and
  • Gyeong Hoon Kang3Email author
BMC Gastroenterology201515:128

DOI: 10.1186/s12876-015-0349-4

Received: 22 December 2014

Accepted: 16 September 2015

Published: 6 October 2015

Abstract

Background

Mucosal Schwann-cell hamartoma is a rare mesenchymal polyp that presents in the intestine. Despite lacking ganglion cells, it resembles a gastrointestinal ganglioneuroma.

Case presentation

We report a case of synchronous mucosal Schwann-cell hamartomas in a young male patient, who presented with a single discrete polyp in the mid-rectum and multiple polypoid mucosal lesions in the distal rectum.

Conclusion

To the best of our knowledge, this is the first report of a case of multiple mucosal Schwann-cell hamartomas.

Keywords

Schwann cells Hamartomas Colon polyps Ganglioneuroma

Background

Colonoscopy is the most effective tool for detecting colorectal cancers and colorectal polyps [1]. Most colorectal polyps, including conventional adenomas (e.g., tubular, villous, and tubulovillous adenomas) and serrated polyps (e.g., hyperplastic polyps, sessile serrated adenomas, and traditional serrated adenomas), are premalignant epithelial polyps. Mesenchymal polyps that protrude into the intestinal lumen are rare; however, their detection rate can be improved with screening colonoscopy. Based on histomorphology and cells of origin, intestinal mesenchymal polyps are classified into various categories, including gastrointestinal stromal tumors, smooth muscle tumors, lipogenic tumors, and neural tumors.

Gastrointestinal neural tumors include ganglioneuromas, perineuromas, schwannomas and neurofibromas. In 2009, Gibson et al. reported 26 cases of colorectal polyps that demonstrated pure Schwann cell proliferation in the lamina propria not associated with neurofibromatosis type 1 (NF1), and designated these polyps as mucosal Schwann-cell hamartomas [2]. Based on histomorphology, mucosal Schwann-cell hamartomas can be distinguished by schwannomas which have Verocay bodies, Antoni A and Antoni B areas and lymphoid cuffs. Neurofibromas can be distinguished by the presence of fibroblasts, perineurial-like cells and axons, and ganglioneuromas can be distinguished by the presence of ganglion cells. Although multiple polyps can develop in certain gastrointestinal neural tumors, such as neurofibromas and ganglioneuromas, it is unclear whether mucosal Schwann-cell hamartomas are associated with multiple polyps [2].

In this report, we describe a case of synchronous mucosal Schwann-cell hamartomas in a young adult, who presented with a single discrete polyp in the mid-rectum and multiple polyposis-like mucosal lesion in the distal rectum. We finally suggest multiple mucosal Schwann-cell hamartomas or mucosal Schwann-cell hamartomatosis as the possible diagnosis.

Case presentation

A 20-year-old man visited the Armed Forces Capital Hospital with symptoms of abdominal discomfort and loose stools. His mother had a history of early stage colorectal cancer and his grandfather died of colorectal cancer. Physical examination of the head, neck, lungs, heart, skin and other systems was unremarkable. He had normal bowel sounds with no abdominal tenderness or palpable abdominal mass. On procto-colonoscopic examination, a 4-mm sized polyp was observed in the mid-rectum (Fig. 1a), and scattered tiny polyp-like mucosal elevations were observed in the distal rectum (Fig. 1b). The polyp in the mid-rectum was removed by biopsy forceps, and three pieces of rectal mucosa in the distal rectum were randomly sampled. On microscopic examination, the polyp in the mid-rectum and one of the three pieces obtained from the distal rectum showed plexiform proliferation of spindle cells in the lamina propria, intervening the adjacent crypts. In addition, microscopy revealed that all cells were spindle-shaped and had elongated tapered nuclei, amphophilic to eosinophilic cytoplasm with indistinct cell borders, and no nuclear atypia, pleomorphism or mitoses. On immunohistochemical analysis, the lesions showed diffuse strong positivity for S-100 protein and no activity for CD117, CD34, epithelial membrane antigen (EMA), smooth muscle actin, and synaptophysin (Fig. 2). Neurofilament protein (NFP) stain showed no positive axon. We sequenced all exons of the NF1 and RET genes using DNA derived from the blood leukocytes of the patient and found no evidence of a disease-causing mutation. To rule out NF1 mosaicism, we performed targeted resequencing (Ion Ampliseq™ Comprehensive Cancer Panel, Life technologies®) of NF1 genes using DNA extracted from formalin-fixed paraffin-embedded tissues of the lesion, and found no disease-causing mutation in NF1 gene of the lesion. Considering the histological findings and the immunohistochemical results, we diagnosed these polyps as mucosal Schwann-cell hamartomas.
Fig. 1

Proctoscopic findings. a. A 4-mm sized polyp in the mid-rectum, b. A polyposis-like mucosal lesion in the distal rectum

Fig. 2

Histologic findings of mucosal Schwann-cell hamartomas. a. A polyp in the mid-rectum (H&E, x40), b. A polyposis-like mucosal lesion in the distal rectum (H&E, x40), c. Strong positive immunoreactivity for S-100 (x40), d. Negativity for synaptophysin (x40)

Conclusion

Intestinal polyps containing neural proliferations in the lamina propria and lacking ganglion cells have been referred as “neuromas” or “neurofibromas”. However, some of these polyps are solely composed of S-100-positive Schwann cells, which distinguish them from true “neuromas” and “neurofibromas”. In 2009, Gibson et al. named these lesions “mucosal Schwann-cell hamartomas”[2]. Since then, only a few case reports have described these lesions [35]. Notably, there is limited literature on characterization of clinical features of mucosal neural proliferative lesions as these lesions are rare and only incidentally found [6]. In 2013, Bae et al. reported a case of mucosal Schwann-cell hamartoma in a 41-year-old woman and provided a literature review of 32 cases of mucosal Schwann-cell hamartomas [7]. The median age of the 32 patients at diagnosis of mucosal Schwann-cell hamartomas was 59 (range: 34 – 88) and the male to female ratio was 0.68:1 (13 males and 19 females). Mucosal Schwann-cell hamartomas were more frequent in the distal colorectum relative to the splenic flexure than in the proximal colon – in 32 cases reviewed, lesions were in the proximal colon in six cases and in the distal colorectum in the remaining 26 cases. Most reported cases of mucosal Schwann-cell hamartomas developed as a single polyp. In fact, it is not known whether mucosal Schwann-cell hamartoma can develop into multiple/diffuse polyps.

Mucosal Schwann-cell hamartomas are composed of uniform, bland spindle cells with elongated, tapering, or wavy nuclei, abundant dense cytoplasm, and indistinct cell borders. These cells entrap the colonic crypts without whirling, palisading, or fascicular architecture. These lesions show diffuse positivity for S-100 and NFP stain often shows rare axons. In fact, a diagnosis of mucosal Schwann-cell hamartomas should be made by excluding resembling lesions by careful histologic examination. Neurofibromas consist of heterogeneous cellular compositions, including Schwann cells, fibroblasts, perineurial-like cells and NFP-positive scattered axons [2]. Mucosal neuromas consist of disorganized and tortuous nerve bundles surrounded by a thickened perineurium that is positive for EMA [8]. Ganglioneuromas are composed of ganglion cells, nerve fibers, and Schwann cells [2].

Certain types of intestinal neural tumors develop as multiple or diffuse polypoid lesions in the context of inherited syndromes. Gastrointestinal neurofibromas have a strong association with NF1; however, a few sporadic intestinal neurofibromas have also been reported [9]. Diagnosis of NF1 can be based on clinical diagnostic criteria and confirmation of germline NF1 mutation. Detection of NF1 mutation may be challenging due to the large size of NF1 gene and the lack of hotspot mutation [10]. Sanger sequencing can detect 88.8% of NF1 mutation, whereas ancillary methods such as multiplex ligation-dependent probe amplification and targeted next generation sequencing improve the detection rate to 97% [10]. Mucosal neuromas are highly associated with multiple endocrine neoplasia type 2b (MEN-2b), which occurs in patients with germline mutation of RET genes [11]. Intestinal ganglioneuromatous polyposis and diffuse ganglioneuromatosis affect individuals with familial adenomatous polyposis, Cowden syndrome, tuberous sclerosis, NF1, MEN-2b and juvenile polyposis [6].

In this report, we presented a case of synchronous mucosal Schwann-cell hamartomas located in the mid-rectum and in the distal rectum of a young adult. We were unable to inspect the entire polypoid mucosal lesion in the distal rectum in this patient because of the benign nature of mucosal Schwann-cell hamartomas. Although we cannot exclude the possibility of ganglion cells in the remaining areas of the polypoid mucosa, we confirmed the absence of ganglion cells in the specimens by immunohistochemical analysis. In addition, we confirmed the absence of germline mutations in the NF1 gene and in the RET gene by Sanger sequencing of leukocyte DNA and the absence of NF1 mosaicism by targeted resequencing of the lesion. To the best of our knowledge, this is the first report of a mucosal Schwann-cell hamartoma in an adult under 30 years of age and also of a case of synchronous mucosal Schwann-cell hamartomas. Particularly, we suggest multiple mucosal Schwann cell hamartomas or mucosal Schwann-cell hamartomatosis as the likely diagnosis.

In summary, we presented a case of synchronous mucosal Schwann-cell hamartomas in a young adult and suggested multiple mucosal Schwann-cell hamartomas or mucosal Schwann-cell hamartomatosis as the possible diagnosis.

Consent

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor in Chief of this journal.

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Pathology, The Armed Forces Capital Hospital
(2)
Department of Internal Medicine, The Armed Forces Capital Hospital
(3)
Department of Pathology, Seoul National University College of Medicine
(4)
Division of Gastroenterology, Department of Internal Medicine, Korea University Kuro Hospital
(5)
Department of Internal Medicine, Korea University College of Medicine

References

  1. Lieberman DA, Williams JL, Holub JL, Morris CD, Logan JR, Eisen GM, et al. Colonoscopy utilization and outcomes 2000 to 2011. Gastrointest Endosc. 2014;80(1):133–43. e133.View ArticlePubMedGoogle Scholar
  2. Gibson JA, Hornick JL. Mucosal Schwann cell “hamartoma”: clinicopathologic study of 26 neural colorectal polyps distinct from neurofibromas and mucosal neuromas. Am J Surg Pathol. 2009;33(5):781–7.View ArticlePubMedGoogle Scholar
  3. Pasquini P, Baiocchini A, Falasca L, Annibali D, Gimbo G, Pace F, et al. Mucosal Schwann cell “Hamartoma”: a new entity? World J Gastroenterol. 2009;15(18):2287–9.View ArticlePubMedPubMed CentralGoogle Scholar
  4. de Beca FF, Lopes J, Macoas F, Carneiro F, Lopes JM. Tactoid body features in colon mucosal Schwann cell hamartoma. Int J Surg Pathol. 2013;22(5):438–41.View ArticleGoogle Scholar
  5. Sagami S, Fukumoto A, Amano M, Yamao K, Hashimoto Y, Iiboshi T, et al. [A case of mucosal Schwann cell hamartoma]. Nihon Shokakibyo Gakkai Zasshi. 2012;109(1):1776–83.PubMedGoogle Scholar
  6. Rittershaus AC, Appelman HD. Benign gastrointestinal mesenchymal BUMPS: a brief review of some spindle cell polyps with published names. Arch Pathol Lab Med. 2011;135(10):1311–9.View ArticlePubMedGoogle Scholar
  7. Bae MN, Lee JE, Bae SM, Kim EY, Kim EO, Jung SH, et al. Mucosal schwann-cell hamartoma diagnosed by using an endoscopic snare polypectomy. Ann Coloproctol. 2013;29(3):130–4.View ArticlePubMedPubMed CentralGoogle Scholar
  8. Cangiarella J, Jagirdar J, Adelman H, Budzilovich G, Greco MA. Mucosal neuromas and plexiform neurofibromas: an immunocytochemical study. Pediatr Pathol. 1993;13(3):281–8.View ArticlePubMedGoogle Scholar
  9. Carter JE, Laurini JA. Isolated intestinal neurofibromatous proliferations in the absence of associated systemic syndromes. World J Gastroenterol. 2008;14(42):6569–71.View ArticlePubMedPubMed CentralGoogle Scholar
  10. Sabbagh A, Pasmant E, Imbard A, Luscan A, Soares M, Blanche H, et al. NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience. Hum Mutat. 2013;34(11):1510–8.View ArticlePubMedGoogle Scholar
  11. Lee MJ, Chung KH, Park JS, Chung H, Jang HC, Kim JW. Multiple endocrine neoplasia type 2B: early diagnosis by multiple mucosal neuroma and its DNA analysis. Annals Dermatol. 2010;22(4):452–5.View ArticleGoogle Scholar

Copyright

© Kang et al. 2015

Advertisement